Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
1
17%
Ph phase_3
4
67%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 34 (66.7%)

Trials by Status

unknown117%
completed467%
not_yet_recruiting117%

Recent Activity

0 active trials
Showing 5 of 6
not_yet_recruitingphase_2

Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies

NCT07636486
completedphase_3

A Study of Mircera for the Treatment of Anemia in Dialysis Patients

NCT00077597
completedphase_3

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

NCT01478971
completedphase_3

A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.

NCT00546481
unknownphase_1

Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth

NCT00491413
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07636486Phase 2

Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies

Not Yet Recruiting
NCT00077597Phase 3

A Study of Mircera for the Treatment of Anemia in Dialysis Patients

Completed
NCT01478971Phase 3

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

Completed
NCT00546481Phase 3

A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.

Completed
NCT00491413Phase 1

Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth

Unknown
NCT00322413Phase 3

Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6